Alcon (ALC) Operating Income Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alcon (ALC) Operating Income Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 13.06% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -0.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -65.59% |
| Mar 31, 2026 | 2.90% |
| Dec 31, 2025 | 146.10% |
| Sep 30, 2025 | 17.43% |
| Jun 30, 2025 | 7.29% |
| Dec 31, 2024 | 29.47% |
| Sep 30, 2024 | 155.10% |
| Jun 30, 2024 | 11.57% |
| Mar 31, 2024 | 35.17% |
| Dec 31, 2023 | 34.47% |
| Sep 30, 2023 | 62.25% |
| Jun 30, 2023 | 37.14% |
| Mar 31, 2023 | 126.18% |
| Dec 31, 2022 | 28.31% |
| Sep 30, 2022 | 137.46% |
| Jun 30, 2022 | 79.40% |
| Mar 31, 2022 | 92.43% |
| Dec 31, 2021 | 64.19% |
| Sep 30, 2021 | 27.45% |
| Jun 30, 2021 | 81.98% |